Headlands Research
Latest round
- Series A
Last raised
- Jan 2018
Total raised
- Undisclosed
Investors
- 1
About Headlands Research
Headlands Research, Inc.-based integrated clinical trial site organization dedicated to advancing innovative medical therapies through highly efficient and inclusive clinical trial operations. Founded in 2018 in Mill Valley, US, Headlands Research, Inc. focuses on conducting clinical trials for medical advancements. In August 2025, Thomas H. Lee Partners agreed to acquire a majority stake in Headlands Research, Inc. from KKR for approximately USD 600 million. Headlands Research operates as a multinational integrated clinical trial site organization, primarily focused on conducting clinical trials that advance innovative medical therapies. Its core offerings encompass extensive site databases and physician partnerships, aimed at facilitating large-volume recruitment and retention of diverse and inclusive populations for clinical studies. By leveraging a network of experienced principal investigators and clinical research professionals, Headlands Research provides operational excellence and high-quality data across a broad range of therapeutic areas, including central nervous system (CNS) disorders, mental health, and vaccines. The company serves a wide client base, including pharmaceutical companies, biotechnology firms, and contract research organizations (CROs), operating across multiple geographical markets in North America, Europe, and Asia.Headlands Research generates revenue primarily through partnerships with pharmaceutical companies, biotechnology firms, and contract research organizations that engage its services for conducting clinical trials. The transaction structure typically involves B2B collaborations, where clients contract Headlands Research to deliver clinical trial services, encompassing participant recruitment, trial management, and data collection. Revenue streams are derived from service agreements that outline specific deliverables, timelines, and performance metrics. While specific pricing plans for services are proprietary, they are determined based on the complexity and duration of each clinical trial project. Headlands Research's extensive capabilities in managing large-scale trials and its rigorous approach to participant care contribute to its standing as a trusted partner in advancing medical research initiatives.'s reach, invest in technology and centralized infrastructure, and enhance its capabilities.
Who invested in Headlands Research
1 investor across 1 round
See all investors in Headlands Research
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 6, 2018
Amount
Undisclosed
Investors
Questions about Headlands Research
Who invested in Headlands Research?
Headlands Research has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Headlands Research raised?
Headlands Research has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Headlands Research last raise money?
Headlands Research's most recent round on record is a Series A, in Jan 2018.
What does Headlands Research do?
Headlands Research is a pharmaceuticals company.
Where is Headlands Research headquartered?
Headlands Research is headquartered in Lake Worth, US.
Which VCs invest in companies like Headlands Research?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Headlands Research's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Headlands Research? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.